ENVB Stock: Enveric Biosciences, Inc. Stock Price, Analysis & Insights
Get live envb stock price $6.04, comprehensive Enveric Biosciences, Inc. stock analysis, charts, news, and expert forecast. Real-time envb stock data and investment insights.
Loading chart...
Company Overview
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Company Information
- CEO
- Joseph Edward Tucker
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 5
Contact Information
- Website
- https://www.enveric.com
- Address
- 4851 Tamiami Trail North
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 0.0)
✓ Lower volatility stock (Beta: 0.27) may provide portfolio stability
Business Model & Strategy
Enveric Biosciences, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Joseph Edward Tucker, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Enveric Biosciences, Inc. competes in the Biotechnology within the broader Healthcare. With 3.6 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Enveric Biosciences, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Enveric Biosciences, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Enveric Biosciences, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Enveric Biosciences, Inc.
- ⚠Investors should consider how Enveric Biosciences, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.61M
P/E Ratio
0.01
Beta
0.27
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 3.61M market capitalization
- Trading Volume: 1.26M shares traded today
- Price Range: 52-week range of $4.88 - $1444.50
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Enveric Biosciences, Inc.
Enveric Biosciences, Inc. (ENVB) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 3.61M, the company represents a significant player in its market. The stock is currently trading at $6.04 with a negativedaily change of 41.53%.
The company's 5 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 0.01, beta of 0.27, and 52-week price range from $4.88 to $1444.50when evaluating investment opportunities.
Why Invest in Enveric Biosciences, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Joseph Edward Tucker
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.